T-DM1/pertuzumab tops standard therapy in HER2-positive BC

Options

http://www.medpagetoday.com/MeetingCoverage/AACR/5...


High Marks for Novel Neoadjuvant Regimen

T-DM1/pertuzumab tops standard therapy in HER2-positive breast cancer

Categories